Effect of Perioperative Hydration After Rheolytic Thrombectomy for Iliofemoral Deep Vein Thrombosis

Objective This study aims to compare the efficacy and safety of AngioJet rheolytic thrombectomy vs. catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis. Methods Between the period of February 2015 and October 2016, 65 patients with documented acute lower extremity deep vein thrombosis were treated with catheter-directed intervention. These patients were divided into two groups: AngioJet group and catheter-directed thrombolysis group. Comparisons were made with regard to efficacy and safety between these two groups. Results In the AngioJet group, complete or partial thrombus removal was accomplished in 23 (72%) and 3 (9%) patients, respectively. In the catheter-directed thrombolysis group, complete or partial thrombus removal was accomplished in 27 (82%) patients and 1 (3%) patient, respectively. In the AngioJet group, the perimeter difference between the suffered limb and healthy one declined from 5.1 ± 2.3 cm to 1.4 ± 1.2 cm ( P < 0.05). In the catheter-directed thrombolysis group, the perimeter difference declined from 4.7 ± 1.6 cm to 1.5 ± 0.9 cm ( P < 0.05). The mean urokinase dose was 0.264 ± 0.135 million units in the AngioJet group and 1.869 ± 0.528 million units in the catheter-directed thrombolysis group ( P < 0.05). The duration of thrombolysis was 4.2 ± 1.7 h in the AngioJet group and 73.6 ± 18.3 h in the catheter-directed thrombolysis group ( P < 0.05). The occurrence of complications in these two groups was 19% and 18%, respectively (not significant). Conclusion AngioJet rheolytic thrombectomy is a new, safe and effective approach for treating acute lower extremity deep vein thrombosis. When compared to catheter-directed thrombolysis, this treatment provides similar success with lower urokinase dosage and shorter duration of thrombolysis.

Download Full-text

Catheter-Directed Thrombolysis with Percutaneous Rheolytic Thrombectomy Versus Thrombolysis Alone in Upper and Lower Extremity Deep Vein Thrombosis

CardioVascular and Interventional Radiology ◽

10.1007/s00270-005-0341-4 ◽

2006 ◽

Vol 29 (6) ◽

pp. 1003-1007 ◽

Cited By ~ 50

Author(s):

Hyun S. Kim ◽

Ajanta Patra ◽

Ben E. Paxton ◽

Jawad Khan ◽

Michael B. Streiff

Keyword(s):

Deep Vein Thrombosis ◽

Lower Extremity ◽

Vein Thrombosis ◽

Catheter Directed Thrombolysis ◽

Rheolytic Thrombectomy ◽

Deep Vein

Download Full-text

Abstract No. 145: Mid term results of the PEARL (Peripheral use of AngioJet Rheolytic thrombectomy with mid-Length catheters) registry for deep vein thrombosis

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2009.12.301 ◽

2010 ◽

Vol 21 (2) ◽

pp. S57 ◽

Cited By ~ 1

Author(s):

R. Lookstein ◽

L. Blitz ◽

E. Simoni

Keyword(s):

Deep Vein Thrombosis ◽

Vein Thrombosis ◽

Rheolytic Thrombectomy ◽

Deep Vein ◽

Mid Term Results

Download Full-text

A rare cause of acute pancreatitis: Percutaneous mechanical rheolytic thrombectomy of deep venous thrombosis

Vascular ◽

10.1177/1708538114560454 ◽

2014 ◽

Vol 23 (5) ◽

pp. 545-549 ◽

Cited By ~ 4

Author(s):

Param Dass ◽

Jason Robertson ◽

Carl Muthu ◽

Andrew Holden

Keyword(s):

Acute Pancreatitis ◽

Deep Vein Thrombosis ◽

Case Report ◽

Venous Thrombosis ◽

Clinical Presentation ◽

Rare Complication ◽

Effective Treatment Option ◽

Vein Thrombosis ◽

Rheolytic Thrombectomy ◽

Deep Vein

Introduction Percutaneous mechanical rheolytic thrombectomy is an effective treatment option for deep vein thrombosis as well as arterial and graft thromboses. Acute pancreatitis, a rare complication of this technique, is described in this case report. Case report A 40-year-old man underwent AngioJet mechanical rheolytic thrombectomy for iliocaval deep vein thrombosis. He subsequently developed acute pancreatitis. This case report outlines the clinical presentation of acute pancreatitis after rheolytic thrombectomy and also discusses the possible pathogenesis and etiological factors.

Download Full-text

Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access

Phlebology The Journal of Venous Disease ◽

10.1177/0268355518790407 ◽

2018 ◽

Vol 34 (4) ◽

pp. 257-265 ◽

Cited By ~ 4

Author(s):

Guang Liu ◽

Zhen Zhao ◽

Chaoyi Cui ◽

Kaichuang Ye ◽

Minyi Yin ◽

...

Keyword(s):

Deep Vein Thrombosis ◽

Femoral Access ◽

Technical Success Rate ◽

Vein Thrombosis ◽

Catheter Directed Thrombolysis ◽

Rheolytic Thrombectomy ◽

Complete Lysis ◽

Acute Deep Vein Thrombosis ◽

Deep Vein

Purpose The aim of the present study was to report the clinical outcomes of endovascular treatment for extensive lower limb deep vein thrombosis with AngioJet rheolytic thrombectomy (ART) plus catheter-directed thrombolysis (CDT) using a contralateral femoral approach. Methods A retrospective analysis of consecutive ART+CDT treatments in 38 deep vein thrombosis patients (LET I-III, from September 2014 to March 2016) was performed. Results The technical success rate was 100%. Complete lysis was achieved in 82% of LET III segments (calf veins), 87% of LET II segments (popliteal-femoral veins), and 90% of LET III segments (iliac veins). The best results were obtained in patients treated within seven days of symptom onset. During follow-up, well-preserved, competent femoral valves were observed in 86% of the patients, and recanalization of LET III, LET II, and LET I segments was achieved in 100%, 94%, and 91% of the patients, respectively. The post-thrombotic syndrome rate was 17% during a mean 20-month follow-up.

Download Full-text